Impact of trial design on the estimation of drug potency and power in clinical trials of haemophilia with inhibitors

Malte Selch Larsen, Rasmus Vestergaard Juul, Mads Kreilgaard, Annemarie T. Kristensen, Ulrika S. H. Simonsson

    Research output: Contribution to journalJournal articleResearchpeer-review

    3 Citations (Scopus)
    Original languageEnglish
    JournalEuropean Journal of Pharmaceutical Sciences
    Volume123
    Pages (from-to)531-538
    ISSN0928-0987
    DOIs
    Publication statusPublished - 15 Oct 2018

    Keywords

    • Haemophilia with inhibitors
    • Clinical trial design
    • Repeated time-to-event modelling
    • Drug potency
    • Statistical power

    Cite this